Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$450K Sell
4,041
-332
-8% -$39.3K 0.16% 137
2025
Q4
$590K Buy
4,373
+24
+0.6% +$2.62K 0.21% 102
2025
Q3
$369K Buy
+4,349
New +$267K 0.14% 155

Other funds holding ABVX

Colonial River Investments's ABVX Position: Q1 2026 in Review

Colonial River Investments reduced its Abivax (ABVX) stake by 7.6% in Q1 2026, selling an estimated $39.3K and leaving 4,041 shares worth $450K. The position accounts for 0.16% of the portfolio, ranked #137.

Colonial River Investments first reported a position in ABVX in Q3 2025 and has held it in 3 quarters since. The position peaked at $590K in Q4 2025. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Colonial River Investments held 4,041 shares of Abivax worth $450K as of Q1 2026.
  • Colonial River Investments sold 332 Abivax shares in Q1 2026, an estimated $39.3K.
  • Abivax made up 0.16% of Colonial River Investments's portfolio in Q1 2026, its #137 holding.
  • Colonial River Investments first reported a position in Abivax in Q3 2025 and has held it in 3 quarters since.
  • Colonial River Investments's Abivax position peaked at $590K in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Colonial River Investments's 13F filing for Q1 2026, filed 27 Apr 2026.